Solid Biosciences (SLDB)
Advancing gene therapy candidates for Duchenne and other rare neuromuscular and cardiac diseases.
$8.88
vs last close+0.34 (+4.00%)
Something off on this page? Send us feedback.
Next report
Nov 2, 26
in 41 days
EPS estimate
−$0.37
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.89−$0.59−$0.42−$0.48−$0.50−$0.52−$0.38Pending
Estimate−$0.79−$0.53−$0.51−$0.42−$0.51−$0.40−$0.46−$0.37
Surprise−12.7%−11.3%+17.6%−14.3%+2.0%−30.0%+17.8%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.59 | — | — |
| Sep 2028 | −$0.60 | — | — |
| Jun 2028 | −$0.55 | — | — |
| Mar 2028 | −$0.57 | — | — |
| Dec 2027 | −$0.41 | — | — |
| Sep 2027 | −$0.45 | — | — |
| Jun 2027 | −$0.44 | — | — |
| Mar 2027 | −$0.44 | — | — |
| Dec 2026 | −$0.43 | — | — |
| Nov 2026 | −$0.37 | — | — |
| Aug 2026 | −$0.46 | −$0.38 | +17.8% |
| May 2026 | −$0.40 | −$0.52 | −30.0% |
| Mar 2026 | −$0.51 | −$0.50 | +2.0% |
| Nov 2025 | −$0.42 | −$0.48 | −14.3% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| Apr 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Jan 2018 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Mar 2016 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.59 | — | — | $49.7M | — | — | — |
| Sep 2028 | −$0.60 | — | — | $40.3M | — | — | — |
| Jun 2028 | −$0.55 | — | — | $33.1M | — | — | — |
| Mar 2028 | −$0.57 | — | — | $23.7M | — | — | — |
| Dec 2027 | −$0.41 | — | — | $12.9M | — | — | — |
| Sep 2027 | −$0.45 | — | — | $1.2M | — | — | — |
| Jun 2027 | −$0.44 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.44 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.43 | — | — | $0 | — | — | — |
| Nov 2, 2026 | −$0.37 | — | — | $0 | — | — | — |
| Aug 6, 2026 | −$0.46 | −$0.38 | +17.8% | — | — | — | −3.7% |
| May 12, 2026 | −$0.40 | −$0.52 | −30.0% | — | — | — | +0.5% |
| Mar 19, 2026 | −$0.51 | −$0.50 | +2.0% | — | — | — | −1.3% |
| Nov 3, 2025 | −$0.42 | −$0.48 | −14.3% | — | — | — | −3.5% |
| Aug 12, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 6, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 15, 2024 | |||||||
| Mar 13, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 23, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| Apr 27, 2022 | |||||||
| Mar 14, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Aug 16, 2021 | |||||||
| May 14, 2021 | |||||||
| Mar 15, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 7, 2020 | |||||||
| Mar 12, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 14, 2019 | |||||||
| May 13, 2019 | |||||||
| Mar 13, 2019 | |||||||
| Nov 13, 2018 | |||||||
| Aug 10, 2018 | |||||||
| May 10, 2018 | |||||||
| Mar 29, 2018 | |||||||
| Jan 29, 2018 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Mar 31, 2016 |